Abstract:BACKGROUND:Patients with chronic liver diseases (CLDs) often suffer from lipidosis or siderosis. Proton density fat fraction (PDFF) and R2* can be used as quantitative parameters to assess the fat/iron content of the liver. The aim of this study was to evaluate the influence of liver fibrosis and inflammation on the 3D Multi-echo Dixon (3D ME Dixon) parameters (MRI-PDFF and R2*) in patients with CLDs and to determine the feasibility of 3D ME Dixon technique for the simultaneous assessment of liver steatosis and iron overload using histopathologic findings as the reference standard.METHODS:Ninety-nine consecutive patients with CLDs underwent T1-independent, T2*-corrected 3D ME Dixon sequence with reconstruction using multipeak spectral modeling on a 3T MR scanner. Liver specimen was reviewed in all cases, grading liver steatosis, siderosis, fibrosis, and inflammation. Spearman correlation analysis was performed to determine the relationship between 3D ME Dixon parameters (MRI-PDFF and R2*) and histopathological and biochemical features [liver steatosis, iron overload, liver fibrosis, inflammation, alanine aminotransferase (ALT), aspartate aminotransferase (AST), total bilirubin (TBIL)]. Multiple regression analysis was applied to identify variables associated with 3D ME Dixon parameters. Receiver operating characteristic (ROC) analysis was performed to determine the diagnostic performance of these parameters to differentiate liver steatosis or iron overload.RESULTS:In multivariate analysis, only liver steatosis independently influenced PDFF values (R2=0.803, P<0.001), liver iron overload and fibrosis influenced R2* values (R2=0.647, P<0.001). The Spearman analyses showed that R2* values were moderately correlated with fibrosis stages (r=0.542, P<0.001) in the subgroup with the absence of iron overload. The area under the ROC curve of PDFF was 0.989 for the diagnosis of steatosis grade 1 or greater, and 0.986 for steatosis grade 2 or greater. The area under the ROC curve of R2* was 0.815 for identifying iron overload grade 1 or greater, and 0.876 for iron overload grade 2 or greater.CONCLUSIONS:3D Multi-Echo Dixon can be used to simultaneously evaluate liver steatosis and iron overload in patients with CLDs, especially for quantification of liver steatosis. However, liver R2* value may be affected by the liver fibrosis in the setting of CLDs with absence of iron overload.

Integrated quantitative susceptibility and R2 * mapping for evaluation of liver fibrosis: An ex vivo feasibility study

Magnetic Resonance Quantitative Susceptibility Mapping in the Evaluation of Hepatic Fibrosis in Chronic Liver Disease: a Feasibility Study

T1 Mapping, T2 Mapping and MR Elastography of the Liver for Detection and Staging of Liver Fibrosis.

MRI quantification of liver fibrosis using diamagnetic susceptibility: An ex-vivo feasibility study

Quantitative Susceptibility Mapping (Qsm) Minimizes Interference From Cellular Pathology In R2(Star) Estimation Of Liver Iron Concentration

Assessment of Liver Fibrosis by Variable Flip Angle T-1 Mapping at 3.0T

Serological Diagnosis Of Liver Fibrosis By Quantitative Estimation Of Serum Biomarkers Using Luminex Xmap Assay

Magnetic Susceptibility and R2*-based Texture Analysis for Evaluating Liver Fibrosis in Chronic Liver Disease.

Diffusion-weighted Imaging and Variable Flip Angle T1 Mapping: a Supplement for Image-Guided Biopsy in Follow-Up Analysis of Liver Fibrosis

Assessment of Liver Fibrosis Using Pharmacokinetic Parameters of Dynamic Contrast-Enhanced Magnetic Resonance Imaging.

Quantitative Susceptibility Mapping in Combination with Water-Fat Separation for Simultaneous Liver Iron and Fat Fraction Quantification

Dynamic Changes of Key Metabolites During Liver Fibrosis in Rats.

Recent advances in molecular magnetic resonance imaging of liver fibrosis.

Data adaptive regularization with reference tissue constraints for liver quantitative susceptibility mapping

Quantification of Liver Iron Concentration Using the Apparent Susceptibility of Hepatic Vessels.

Hepatic Fibrosis: Evaluation with Semiquantitative Contrast-enhanced CT

Combined morphological and functional liver MRI using spin-lattice relaxation in the rotating frame (T1ρ) in conjunction with Gadoxetic Acid-enhanced MRI

Measurement of Liver T1 and T2 Relaxation Times in an Experimental Mouse Model of Liver Fibrosis

Three-dimensional Magnetic Resonance Elastography Combining Proton-Density Fat Fraction Precisely Identifies Metabolic Dysfunction-Associated Steatohepatitis with Significant Fibrosis

3D Multi-Echo Dixon Technique for Simultaneous Assessment of Liver Steatosis and Iron Overload in Patients with Chronic Liver Diseases: a Feasibility Study

Fully automated hybrid approach on conventional MRI for triaging clinically significant liver fibrosis: A multi-center cohort study